| ebi-pharm ag - Wobenzym, magensaftresistente Filmtabletten | | 67943 | | 01 | | Wobenzym | | magensaftresistente Filmtabletten | | M09AB52 | | Trypsin, Kombinationen | | 19.07.2022 | | |
| | Composition | | rutosidum trihydricum 50.00 mg, papainum 32.80 mg corresp. papainum 164 U., bromelainum ex truncus 45.00 mg corresp. bromelainum ex truncus 225 U., trypsinum 24.00 mg corresp. trypsinum 720 U., chymotrypsinum 0.75 mg corresp. chymotrypsinum 300 U., pancreatis pulvis 100.00 mg corresp. pancreatis pulvis 300 U., E 223 in Spuren, maltodextrinum, saccharum max. 33.39 mg, maydis amylum, cellulosum microcristallinum, lactosum monohydricum 126.50 mg, magnesii stearas, amylum pregelificatum, silica colloidalis anhydrica, macrogolum 6000, talcum, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:1, natrii laurilsulfas, macrogolum 6000, talcum, triethylis citras, pro compresso obducto corresp., natrium 0.0032 mg. | | Packungsbestandteile | | | | | | Principe actif | Concentr. |
|---|
| | 45 mg correspond 225 U | | | 0.75 mg correspond 300 U | | Pancreatis Pulvis | 100 mg correspond Pancreatis Pulvis 300 U | | Papaine | 32.8 mg correspond Papaine 164 U | | Rutosidum Trihydricum | 50 mg | | | 24 mg correspond 720 U |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | Überzug | | | | | | | | | | | | conserv. | | | | | | Lactose Monohydrate | 126.5 mg | | | Macrogol | 6000 | | | | | | | Maltodextrine | | | | | | | | | | | | | | | | | | | | Saccharum | 33.39 mg | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | | | |
|
| |
|
